The Yellow Card Scheme is run by the Medicines and Healthcare products Regulatory Agency (MHRA). The Scheme is used to collect information from Healthcare Professionals and patients on suspected Adverse Drug Reactions (ADRs). It is vital in helping the MHRA monitor the safety of the medicines and vaccines that are on the market.

Both Healthcare Professionals and patients can submit information through the Yellow Card website.

Reporting forms and information can be found at or search for MHRA Yellow Card in Google Play or the Apple App Store.

Report an Adverse Reaction to Chugai Pharma UK Ltd
Telephone: +44 (0) 20 8987 5600
Email: [email protected]

Report an Adverse Reaction to Roche Products Ltd
(for Hemlibra ▼, RoActemra and Alecensa ▼ only)
Email: [email protected]

Hemlibra ▼, and RoActemra are biological medicines, Healthcare Professionals should report adverse reactions by brand name and batch number.

▼ This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. See for how to report side effects. To report an adverse reaction please click here for further information.

For information about data processing within the scope of Pharmacovigilance, please refer to our Pharmacovigilance Privacy Notice.